$EHC

Darby John Patrick sold $588K of EHC

Darby John Patrick (EVP, Gen Counsel & Secretary) sold 4,858 shares of Encompass Health Corp (EHC) at $121.09 ($0.59M total) on 2026-08-31.

Original reporting
SEC EDGAR · Darby John Patrick
Published Sep 1, 2026, 4:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EHC
Neutral
medium confidence
Mentioned
$EHC
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EHCNeutralLow
01

Why it matters

The sale is modest and unlikely to affect stock price significantly.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or strategic shifts not disclosed.

Relevance 5/10Novelty 3/10Timing: post-market 2026-08-31

Background

Form 4 filing provides primary disclosure of insider transactions.

Company-level read

Ticker impact

$EHCNeutralMedium confidence
Context

Officer Darby John Patrick sold 4,858 shares of Encompass Health Corp for $588K via open-market transaction.

Expected impact

Potential minor downward pressure, likely within normal volatility range.

Evidence & confidence

Sale amount is under $1M and represents a small fraction of holdings; typical for diversification.

Market effects

Minimal impact on healthcare services sector; insider activity is routine.

Negligible effect on broader market.

None

Counterpoint

Insider may be reallocating capital; could indicate confidence in other opportunities.

Key entities

  • Encompass Health Corp

    U.S.-listed healthcare services provider (NYSE: EHC).

  • Darby John Patrick

    Executive Vice President, General Counsel & Secretary of Encompass Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EHCHighAI 8/10

Encompass Health (EHC): This Rehab Hospital Giant Just Raised Its Own Bar Again

Encompass Health (EHC) reported Q2 revenue of $1.597B, up 9.6%, and adjusted EPS of $1.55, up 10.7%. The company raised full-year guidance for revenue, EBITDA, and EPS. It also increased its stock repurchase authorization to $1B. Patient volume and revenue per discharge grew, but free cash flow fell due to higher capital spending. Long-term debt rose to $2.598B.

$EHCMedAI 8/10

Does Stronger EPS, Higher 2026 Targets, and Bigger Buybacks Change The Bull Case For Encompass Health (EHC)?

Encompass Health (EHC) reported adjusted EPS of $1.55, raised its 2026 outlook, and increased its share buyback program to $1B. The company plans to open new hospitals and add beds, signaling confidence in long-term demand. Analysts project $7.9B revenue and $806.1M earnings by 2029, a 22% upside from current prices. Labor shortages remain a key risk.

$EHCMedAI 8/10

Encompass Health (EHC) Q2 2026 Earnings Call Transcript

Encompass Health (EHC) reported Q2 2026 net operating revenue of $1.597B (+9.6% YoY), adjusted EBITDA of $348M (+9.2%), and adjusted EPS of $1.55 (+10.7%). Full-year 2026 guidance was raised: revenue $6.41B-$6.49B, adjusted EBITDA $1.365B-$1.395B, adjusted EPS $6.02-$6.25. The company also increased its $1B share repurchase authorization.

$EHCMed

Encompass Health Named Top SMidCap Pick by TD Cowen

TD Cowen analyst Ryan Langston reiterated Encompass Health (EHC) as a top small- and mid-cap pick after its strong Q2 FY2026 results. Adjusted EBITDA was $348M (+3% vs consensus), revenue $1.597B (+10%), and EPS $1.55. Same-store volume rose 2.8%. EHC raised FY2026 adjusted EBITDA guidance by $15M and authorized a $1B share repurchase.